阿司匹林血栓预防与全关节置换术后大出血事件减少相关
该单中心回顾性研究纳入2009至2020年行全关节置换术的35860例患者,比较阿司匹林与其他药物预防静脉血栓栓塞时大出血事件的发生率。结果显示阿司匹林组大出血率为0.5%,非阿司匹林组为1.2%;校正混杂因素后,阿司匹林组大出血事件 odds 降低近2倍。
要点
- 阿司匹林组大出血事件发生率为0.5%,非阿司匹林组为1.2%。
- 校正混杂因素后,阿司匹林组大出血事件 odds 降低近2倍。
- 年龄增加、BMI升高、ASA评分高、翻修手术、消化性溃疡病、凝血病、术中输血和主动吸烟与MBE风险增加独立相关。
核心结论
- 与其它化学预防药物相比,阿司匹林用于VTE预防可能与全关节置换术后大出血风险降低相关。
研究设计与样本
- 单中心回顾性研究,纳入2009至2020年间接受全关节置换术的35860例患者。
- 收集人口学变量、合并症、化学预防类型和术中因素,采用单变量、多变量回归及倾向性评分匹配分析。
- 大出血事件采用国际血栓与止血学会科学标准化委员会2010年外科患者大出血标准定义。
主要发现
- 整个队列中270例(0.75%)发生大出血事件。
- 阿司匹林组大出血事件率为0.5%,非阿司匹林组为1.2%。
- 多变量逻辑回归和倾向性评分匹配分析显示,接受阿司匹林的患者大出血事件 odds 降低近2倍。
- 与MBE风险增加独立相关的变量包括年龄增加、体重指数、ASA评分、翻修手术、消化性溃疡病、凝血病、术中输血和主动吸烟。
临床怎么用
- 在全关节置换术后选择VTE预防药物时,可考虑阿司匹林与大出血风险降低的关联。
局限性
- 本研究为单中心回顾性设计,结论需未来随机对照试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is ongoing debate on what is optimal prophylactic agent to reduce venous thromboembolism (VTE) following total joint arthroplasty (TJA). Although many studies assess the efficacy of these agents in VTE prevention, no attention is given to their adverse effect on major bleeding events (MBEs). This study compared the incidence of MBE in patients receiving aspirin as VTE prophylaxis vs other chemoprophylaxis. METHODS: A single-institution, retrospective study of 35,860 patients undergoing TJA between 2009 and 2020 was conducted. Demographic variables, co-morbidities, type of chemoprophylaxis, and intraoperative factors were collected. MBE was defined using the 2010 criteria for major bleeding in surgical patients presented by the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. To enhance capture rate, comprehensive queries utilizing MBE keywords were conducted in clinical notes, physician dictations, and phone call logs. Univariate followed by multivariate regression was performed as well as propensity score matched analysis. RESULTS: Overall, 270 patients (0.75%) in this cohort developed MBE. The MBE rate was 0.5% in the aspirin group and 1.2% in the non-aspirin group. After adjusting for confounders, multiple logistic regression and propensity score matched analysis revealed almost 2 times lower odds of MBE in patients who received aspirin. Variables independently associated with increased MBE risk included increasing age, body mass index, American Society of Anesthesiologists score, revision surgery, peptic ulcer disease, coagulopathy, intraoperative blood transfusion, and active smoking. CONCLUSION: Administration of aspirin for VTE prophylaxis, compared to other chemoprophylaxis agents may have an association with lower risk of major bleeding following TJA. Future randomized controlled trials should examine these findings.
引用
- Shohat N, Ludwick L, Goh GS, et al. Aspirin Thromboprophylaxis Is Associated With Less Major Bleeding Events Following Total Joint Arthroplasty. J Arthroplasty. 2021. PMID: 34648924. doi:10.1016/j.arth.2021.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。